Longwood Fund II, L.P.

Longwood Fund II, L.P. is a declared insider of Salarius Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 3 February 2015 to 16 October 2018, the count stands at 5 filings.

On the open market, the record shows 2 purchases worth €5.0M and 1 sale worth €2.5M. On balance, insiders were net buyers of €2.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2018, the count stands at no purchases and 1 sale.

Most recently, on 18 October 2018, the filings show an open-market sale worth €2.5M in Salarius Pharmaceuticals, Inc. The most recent open-market purchase was published on 15 March 2016, 3,891 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.